Hosted on MSN28m
Supernus (SUPN) Moves to Strong Buy: Rationale Behind the Upgrade
Investors might want to bet on Supernus Pharmaceuticals (SUPN), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in ...
Hosted on MSN28m
Aptiv's Q4 Earnings Beat Estimates, Increase Year Over Year
Aptiv PLC APTV reported mixed fourth-quarter 2024 results, with earnings beating the Zacks Consensus Estimate but revenues ...